慢性肝病发展的病理生理学。
Pathophysiology of Chronic Liver Disease Development.
机构信息
Medical Clinic III, Gastroenterology, Metabolic Diseases and Intensive Care, University Hospital RWTH Aachen, Pauwelsstr. 30, 52074 Aachen, Germany.
出版信息
Int J Mol Sci. 2022 Mar 21;23(6):3385. doi: 10.3390/ijms23063385.
Abstract
Chronic liver disease is a major public threat and the second leading cause of loss of working life years in Europe [...].
摘要
慢性肝病是欧洲的一个主要公共威胁，也是丧失工作生命年的第二大主要原因[... ]。
相似文献
1
Pathophysiology of Chronic Liver Disease Development.慢性肝病发展的病理生理学。
Int J Mol Sci. 2022 Mar 21;23(6):3385. doi: 10.3390/ijms23063385.
2
Aetiology and pathophysiology of chronic liver disorders.慢性肝脏疾病的病因学与病理生理学
Drugs. 1990;40 Suppl 3:3-22. doi: 10.2165/00003495-199000403-00003.
3
Disparities between research attention and burden in liver diseases: implications on uneven advances in pharmacological therapies in Europe and the USA.肝脏疾病研究关注度与负担之间的差距：对欧美药物治疗不均衡进展的影响。
BMJ Open. 2017 Mar 22;7(3):e013620. doi: 10.1136/bmjopen-2016-013620.
4
[The liver and Europe].[肝脏与欧洲]
Gastroenterol Clin Biol. 2009 Aug-Sep;33(8-9):903-7. doi: 10.1016/j.gcb.2009.07.018. Epub 2009 Aug 31.
5
Burden of liver disease in Europe: Epidemiology and analysis of risk factors to identify prevention policies.欧洲肝病负担：流行病学和危险因素分析，以确定预防政策。
J Hepatol. 2018 Sep;69(3):718-735. doi: 10.1016/j.jhep.2018.05.011. Epub 2018 May 17.
6
Apolipoprotein deficiency and chronic liver disease.
J Assoc Physicians India. 2001 Feb;49:274-8.
7
The burden of liver disease in Europe: a review of available epidemiological data.欧洲的肝脏疾病负担：现有流行病学数据综述。
J Hepatol. 2013 Mar;58(3):593-608. doi: 10.1016/j.jhep.2012.12.005.
8
[Autoimmune liver diseases: the relation to other autoimmune pathology].[自身免疫性肝病：与其他自身免疫性病理的关系]
Ter Arkh. 1993;65(2):36-41.
9
Liver manifestations of cystic fibrosis.囊性纤维化的肝脏表现。
Eur J Radiol. 2007 Jan;61(1):11-7. doi: 10.1016/j.ejrad.2006.11.008. Epub 2006 Dec 15.
10
The Effects of Alcohol on Other Chronic Liver Diseases.酒精对其他慢性肝病的影响。
Clin Liver Dis. 2016 Aug;20(3):581-94. doi: 10.1016/j.cld.2016.02.013. Epub 2016 Apr 5.
本文引用的文献
1
The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality.欧洲肝脏研究学会-《柳叶刀》肝脏委员会：保护下一代欧洲人免受肝脏疾病并发症和过早死亡的影响。
Lancet. 2022 Jan 1;399(10319):61-116. doi: 10.1016/S0140-6736(21)01701-3. Epub 2021 Dec 2.
2
Alpha-1 antitrypsin deficiency: A re-surfacing adult liver disorder.α-1抗胰蛋白酶缺乏症：一种再度出现的成人肝脏疾病。
J Hepatol. 2022 Apr;76(4):946-958. doi: 10.1016/j.jhep.2021.11.022. Epub 2021 Nov 27.
3
Alpha-1 Antitrypsin and Hepatocellular Carcinoma in Liver Cirrhosis: MZ or MS Genotype Carriage Decreases the Risk.α-1 抗胰蛋白酶与肝硬化肝癌：MM 或 MS 基因型携带者降低风险。
Int J Mol Sci. 2021 Sep 29;22(19):10560. doi: 10.3390/ijms221910560.
4
Diagnosis and Therapeutic Management of Liver Fibrosis by MicroRNA.miRNA 对肝纤维化的诊断与治疗管理
Int J Mol Sci. 2021 Jul 29;22(15):8139. doi: 10.3390/ijms22158139.
5
Alcohol-Related Liver Disease: Basic Mechanisms and Clinical Perspectives.酒精性肝病：基础机制与临床视角。
Int J Mol Sci. 2021 May 13;22(10):5170. doi: 10.3390/ijms22105170.
6
Expression of Interferons Lambda 3 and 4 Induces Identical Response in Human Liver Cell Lines Depending Exclusively on Canonical Signaling.干扰素 lambda 3 和 4 的表达在人类肝细胞系中诱导相同的反应，完全依赖于经典信号通路。
Int J Mol Sci. 2021 Mar 4;22(5):2560. doi: 10.3390/ijms22052560.
7
From Liver Cirrhosis to Cancer: The Role of Micro-RNAs in Hepatocarcinogenesis.从肝硬化到癌症：MicroRNAs 在肝癌发生中的作用。
Int J Mol Sci. 2021 Feb 2;22(3):1492. doi: 10.3390/ijms22031492.
8
IL-18 but Not IL-1 Signaling Is Pivotal for the Initiation of Liver Injury in Murine Non-Alcoholic Fatty Liver Disease.IL-18 而非 IL-1 信号对小鼠非酒精性脂肪性肝病肝损伤的启动起关键作用。
Int J Mol Sci. 2020 Nov 14;21(22):8602. doi: 10.3390/ijms21228602.
9
miR-29a Modulates GSK3β/SIRT1-Linked Mitochondrial Proteostatic Stress to Ameliorate Mouse Non-Alcoholic Steatohepatitis.miR-29a 通过调节 GSK3β/SIRT1 相关的线粒体稳态应激来改善小鼠非酒精性脂肪性肝炎。
Int J Mol Sci. 2020 Sep 19;21(18):6884. doi: 10.3390/ijms21186884.
10
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease.对非酒精性脂肪性肝病流行情况的建模显示，疾病负担呈指数级增长。
Hepatology. 2018 Jan;67(1):123-133. doi: 10.1002/hep.29466. Epub 2017 Dec 1.
Zotero 插件